We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Acquisitions and Emerging Markets Key to Medical Device Industry

By HospiMedica International staff writers
Posted on 18 Apr 2011
The medical device market should see significant growth over the next few years as a result of emerging markets, an aging population, and increased acquisitions. More...
These are the latest findings of Kalorama Information (New York, NY, USA), an independent market research firm.

Medical device companies saw growth in 2010 despite a slow economy and pressure on pricing, and that growth should continue for the next few years, according to report. Bellwether medical device companies grew at an average of 6% in 2010, on the higher side of most growth estimates a year ago, and Kalorama Information predict that the US$305 billion medical device market should see growth continue in that range over the next few years. Many market leaders chose 2010 to make strategic moves, by either divesting unprofitable areas or acquiring areas that were in line with strategic goals, and where cross-selling opportunities were present.

The medical device market, however, was not without challenges during these moves, including regulatory procedures, group-purchasing negotiations, and a new tax that was introduced as part of US healthcare reform. However, the report pointed to a robust amount of merger and acquisition activity in the market as an indication that the medical device industry is optimistic about the future. Among the acquisitions that occurred during 2010 was the acquisition of endovascular company ev3 (Plymouth, MN, USA) by Covidien (Dublin, Ireland) for $2.6 billion. Orthopedic giant Stryker (Kalamazoo, MI, USA) purchased the neurovascular unit of Boston Scientific, and Baxter Healthcare assumed bone graft maker Apatech (Deerfield, IL, USA). Medtronic acquired several companies, including spinal neuromodulation products manufacturer Axon Systems, heart valve maker ATS Medical and Invatec, a producer of stents.

"It's a healthy sign that so many of the top companies chose 2010 to make strategic moves," said report author Bruce Carlson, publisher of Kalorama Information. "In some categories, such as orthopedics or respiratory, it's simple demographics and improved economics in the developed world that led to growth. For most companies, double-digit growth in orders to India, China, Brazil, and other nations fueled revenues."

Related Links:
Kalorama Information
ev3
Covidien
Stryker
Apatech


Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Heavy-Duty Wheelchair Scale
6495 Stationary
Isolation Stretcher
IS 736
X-Ray System
Leonardo DR mini III
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.